#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Encephalopathy neonatal Superficial vein thrombosis Progressive supranuclear palsy Uveal melanoma Atopic keratoconjunctivitis Soft tissue sarcoma Short stature Non-renal cell carcinoma of kidney Thermal burn Chronic hepatitis B SAPHO syndrome Palmoplantar pustulosis Hereditary optic atrophy Antithrombin III deficiency Primary hyperoxaluria More trials…

    Learn about Rare Diseases

    Indolent systemic mastocytosis Congenital generalised lipodystrophy Haemophilia B with anti factor IX – Treatment Angiosarcoma recurrent – Trials in Disease Haemolytic uraemic syndrome Glycogen storage disease type I – Diagnostics Noonan syndrome – Diagnostics SAPHO syndrome – Treatment Fabry’s disease – Diagnostics Propionic acidaemia – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Chloropyramine Hydrochloride Esflurbiprofen Midostaurin AB521 Clotrimazole Deutivacaftor Namilumab Rimegepant Clofazimine Radium Ra 223 Dichloride Asp1570 HUMAN PLASMA Reparixin Betaxolol Fostemsavir Gd2Il18Cart Abc-35B-116 Charcoal, Activated Cyclophosphamide Levocabastine Hydrochloride More therapies…

    Learn about Your Condition

    Biliary adenoma Micrographic skin surgery Ventricular tachycardia Growth hormone deficiency Amnestic disorder Noonan syndrome Breast cancer stage II Actinic cheilitis Extra-osseous Ewing's sarcoma Arterial stiffness Fabry's disease Intestinal ischaemia Papulopustular rosacea Rectal adenocarcinoma Muscular dystrophy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Acute myocardial infarction

  • Study on Methoxyflurane for Pain Relief in Patients with Heart Attack

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • MORPHINE
    France

  • Study on the Safety and Effectiveness of ApTOLL for Patients with ST Elevation Myocardial Infarction (STEMI)

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Acute myocardial infarction
    • Myocardial infarction
    Investigated Drugs:
    • Aptamer-4Ft
    Spain

  • A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack

    Not recruiting

    3 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Ziltivekimab
    Bulgaria Czechia Denmark France Germany Greece +4

  • Study of Modified Anti-Platelet Therapy with Prasugrel, Ticagrelor, and Clopidogrel in Heart Attack Patients Undergoing Complete Revascularization

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Prasugrel
    • Clopidogrel
    • Acetylsalicylic Acid
    Italy The Netherlands Spain

  • Study on the Effects of Warfarin, Lysine Aspirin, and Clopidogrel in Patients with Myocardial Infarction and Non-Obstructive Coronary Arteries (MINOCA)

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myocardial infarction
    • Myocardial infarction
    Investigated Drugs:
    • Acetylcholine Chloride
    • Diltiazem
    • Glyceryl Trinitrate
    Italy

  • Study on Early vs. Delayed Ticagrelor with Cangrelor for Patients with STEMI Undergoing PCI

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Cangrelor Tetrasodium
    • Ticagrelor
    Italy
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!